Songling Xuemaikang is named as a drug or biological intervention in 3 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Jing Liu (1), Xiyuan Hospital of China Academy of Chinese Medical Sciences (1) and Dongzhimen Hospital, Beijing (1). Registered phases: Not applicable and Phase 4. Conditions studied include Hypertension; Hypertension,Essential; Cerebral Small Vessel Diseases.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06093932 | Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial (ClinicalTrials.gov ↗) Hypertension,Essential |
Phase 4 | Recruiting |
| NCT07271732 | Songling Xuemaikang Capsules for Cerebral Small Vessel Disease (ClinicalTrials.gov ↗) Hypertension, Cerebral Small Vessel Diseases |
Not applicable | Not yet open |
| NCT07709442 | Songling Xuemaikang in Hypertension and Insomnia Evaluation๏ผSHINE๏ผ (ClinicalTrials.gov ↗) Hypertension |
Not applicable | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Hypertension | 2 |
| Hypertension,Essential | 1 |
| Cerebral Small Vessel Diseases | 1 |
| Lead sponsor | Trials |
|---|---|
| Jing Liu | 1 |
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | 1 |
| Dongzhimen Hospital, Beijing | 1 |
| Register | Songling Xuemaikang trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how Songling Xuemaikang works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Songling Xuemaikang (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.